{"filing":{"accession_number":"0001213900-26-093565","cik":"0001739174","ticker":"PHGE","company_name":"BiomX Inc.","form":"8-K","filing_date":"2026-08-25","report_date":"2026-08-25","primary_document":"ea0303308-8k_biomx.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026093565/ea0303308-8k_biomx.htm"},"events":[{"id":29546,"run_id":27057,"accession_number":"0001213900-26-093565","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This Item 5.07 discloses the final results of a Special Meeting of Stockholders held on August 25, 2026, with voting outcomes on four proposals: approval of issuance of shares to Mandragola Ltd. in connection with an acquisition of Dr. Frucht Systems Ltd., approval of a reverse stock split (1-for-5 to 1-for-20), ratification of Barzily \u0026 Co. as independent auditor, and an adjournment proposal. All three substantive proposals passed with strong majorities. The disclosure includes vote counts, abstentions, and broker non-votes as required by Item 5.07, making this a clear shareholder vote results disclosure that is material to investors assessing the company's capital structure and governance decisions.","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-08-25","form":"8-K","submitted_at":null,"items":[{"id":31863,"accession_number":"0001213900-26-093565","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 discloses the final results of a Special Meeting of Stockholders held on August 25, 2026, with voting outcomes on four proposals: approval of issuance of shares to Mandragola Ltd. in connection with an acquisition of Dr. Frucht Systems Ltd., approval of a reverse stock split (1-for-5 to 1-for-20), ratification of Barzily \u0026 Co. as independent auditor, and an adjournment proposal. All three substantive proposals passed with strong majorities. The disclosure includes vote counts, abstentions, and broker non-votes as required by Item 5.07, making this a clear shareholder vote results disclosure that is material to investors assessing the company's capital structure and governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T21:01:54.694843+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":31863,"accession_number":"0001213900-26-093565","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 discloses the final results of a Special Meeting of Stockholders held on August 25, 2026, with voting outcomes on four proposals: approval of issuance of shares to Mandragola Ltd. in connection with an acquisition of Dr. Frucht Systems Ltd., approval of a reverse stock split (1-for-5 to 1-for-20), ratification of Barzily \u0026 Co. as independent auditor, and an adjournment proposal. All three substantive proposals passed with strong majorities. The disclosure includes vote counts, abstentions, and broker non-votes as required by Item 5.07, making this a clear shareholder vote results disclosure that is material to investors assessing the company's capital structure and governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T21:01:54.694843+00:00","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-08-25"}]}